stockrow
Friday 6 November 2026
Export INSP’s income statement to Excel — free account
Inspire Medical Systems, Inc.
INSP Healthcare Medical Devices
Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024.
- Revenue
- −7.93%
- EPS
- −348.0%
- Free cash flow
- −33.1%
Quarter to September 2026, against a year earlier
63.84
2.69
−4.04%
Follow INSP
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 7 | 6 |
+8 more TTM periods Free account |
| 13.49% | 17.96% | 18.37% | 19.77% | ||
| 11.44% | 15.63% | 15.97% | 16.95% | ||
ROIC |
1.97% | 6.70% | 6.31% | 6.73% | |
Return on Tangible Assets |
16.35% | 21.04% | 22.68% | 24.84% | |
Average Days of Receivables |
43.38 | 41.97 | 41.91 | 47.90 | |
Free Cash Flow per Share |
3.38 | 4.06 | 3.37 | 2.67 | |
Free Cash Flow |
97.89 | 117.09 | 96.71 | 78.48 | |
Capital Expenditures |
(37.08) | (39.98) | (39.82) | (38.50) | |
| Other line items | |||||
Cash ROIC |
8.48% | 10.21% | 8.99% | 7.20% | |
Accounts Receivable Turnover |
8.28 | 7.46 | 9.26 | 8.57 | |
Accounts Payable Turnover |
2.50 | 3.11 | 3.67 | 3.54 | |
Inventory Turnover |
0.76 | 0.85 | 0.98 | 1.18 | |
Average Days of Payables |
114.19 | 79.37 | 117.33 | 100.18 | |
Days of Inventory on Hand |
536.73 | 499.17 | 466.07 | 398.06 | |
Tax Rate |
2.27 | 0.95 | 1.05 | 1.21 | |
Research and Development Expense of Revenue |
11.08% | 11.09% | 11.06% | 11.31% | |
Selling, General and Administrative Expense of Revenue |
73.31% | 69.02% | 69.11% | 68.49% | |
Share Based Compensation of Revenue |
13.26% | 13.28% | 14.19% | 14.28% | |
Interest Coverage |
— | — | — | 9.04 | |
Operating CF/Net income |
1.34 | 1.16 | 1.04 | 0.80 | |
Depreciation/Fixed assets |
0.20 | 0.15 | 0.14 | 0.11 | |
Capex/Depreciation |
(2.13) | (2.51) | (2.83) | (3.48) | |
Revenue per Share |
30.45 | 31.17 | 31.89 | 31.05 | |
Operating CF per Share |
4.67 | 5.45 | 4.76 | 3.98 | |
Capex per Share |
(1.28) | (1.39) | (1.39) | (1.31) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 5 Nov 2026